Swiss Unilabs is potential frontrunner in Synlab sale, say sources: Reuters

Swiss-based medical diagnostics group Unilabs, owned by private-equity investors Apax Partners and Nordic Capital, has the potential to become a frontrunner to buy German laboratory operator Synlab in a roughly 1.7 billion euro ($1.9 billion) deal, sources told Reuters.

DealsNorth AmericaUSBriefs